T 0542/23 (Treatment of brain metastases/ARRAY) of 10.01.2025
- European Case Law Identifier
- ECLI:EP:BA:2025:T054223.20250110
- Date of decision
- 10 January 2025
- Case number
- T 0542/23
- Petition for review of
- -
- Application number
- 18162971.8
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- COMPOUNDS FOR USE IN THE TREATMENT OF BRAIN METASTASES IN A PATIENT WITH ERBB2+ BREAST CANCER
- Applicant name
- Array Biopharma, Inc.
- Opponent name
- Teva Pharmaceutical Industries Ltd
Sandoz AG - Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 54(2)European Patent Convention Art 56
- Keywords
- Inventive step - state of the art
Inventive step - standard of proof
Inventive step - obvious solution - Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.